Skip to content

Dogwood Therapeutics DWTX Q4 2024 Annual earnings

Reported February 26, 2025 · Before market open

Next report

Aug 12, 2026 (In 3 weeks)
EPS estimate-$0.13

Financials

Q4 2024

Income statement

See full
Operating income-$7.5M-563%
Net income-$7.7M-601%
EPS (diluted)-$7.57-433%

Balance sheet

See full
Cash & equivalents$14.8M+348%
Total debt$204.6K
Total equity-$10.1M-366%
Total assets$94.3M+2,164%

Cash flow

See full
Operating cash flow-$6.1M-317%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$43M
Enterprise value$28.36M

Returns & leverage

See full
Current ratio5.2×-6.4×

Versus estimates

Ask the moment Dogwood Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dogwood Therapeutics report Q4 2024 earnings?
Dogwood Therapeutics (DWTX) reported Q4 2024 earnings on February 26, 2025 before market open.
What were Dogwood Therapeutics's Q4 2024 revenue and EPS?
Dogwood Therapeutics reported diluted EPS of $-5.90 for Q4 2024.
Did Dogwood Therapeutics beat estimates in Q4 2024?
EPS missed the consensus estimate of $-1.36 by $4.54.
Where can I find Dogwood Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-004167) directly on SEC EDGAR. The filing index links above go to sec.gov.